CXCL12 and prostate carcinoma: Notably, prostate cancer-derived exosomes containing pyruvate kinase M2 (PKM2) upregulate CXCL12 in bone marrow MSCs, which enhances tumor cell seeding and proliferation in the bone marrow [211].